Osama E. Rahma
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Surgical Treatments
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 72
- Cancer Immunotherapy and Biomarkers 54
- Pancreatic and Hepatic Oncology Research 9
- Colorectal Cancer Surgical Treatments 4
- COVID-19 and healthcare impacts 3
-
- Immunotherapy and Immune Responses 5
- Co-authors
- Frank Stephen Hodi (13 shared papers)Patrick Alexander Ott (10 shared papers)Shilpa Grover (12 shared papers)Rawad Elias (3 shared papers)Seth M. Steinberg (7 shared papers)Paul Raymond Kunk (6 shared papers)Anita Giobbie‐Hurder (9 shared papers)Austin G. Duffy (6 shared papers)
- Journals
- Journal for ImmunoTherapy of Cancer (15 papers)Clinical Cancer Research (10 papers)Annals of Oncology (5 papers)Cancer Immunology Immunotherapy (4 papers)Nature Medicine (3 papers)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Osama E. Rahma
101 papers receiving 5.7k citations
Osama E. Rahma's Hit Papers
Peers
Comparison fields: 5 of 72
- Oncology 2.8k
- Hepatology 622
- Immunology 358
- Transplantation 38
- Cancer Research 75
Countries citing papers authored by Osama E. Rahma
This map shows the geographic impact of Osama E. Rahma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osama E. Rahma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osama E. Rahma more than expected).
Fields of papers citing papers by Osama E. Rahma
This network shows the impact of papers produced by Osama E. Rahma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osama E. Rahma. The network helps show where Osama E. Rahma may publish in the future.
Co-authors
The 25 scholars most cited alongside Osama E. Rahma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma Hit paper breakdown → | 2016 | 680 |
| 2 | 2019 | 405 | |
| 3 | 2020 | 382 | |
| 4 | Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial Hit paper breakdown → | 2022 | 277 |
| 5 | 2020 | 255 | |
| 6 | 2018 | 179 | |
| 7 | 2021 | 153 | |
| 8 | 2020 | 144 | |
| 9 | 2021 | 143 | |
| 10 | 2018 | 141 | |
| 11 | 2020 | 130 | |
| 12 | 2022 | 123 | |
| 13 | 2020 | 119 | |
| 14 | 2013 | 118 | |
| 15 | 2016 | 96 | |
| 16 | 2011 | 87 | |
| 17 | 2021 | 87 | |
| 18 | 2018 | 83 | |
| 19 | 2022 | 83 | |
| 20 | 2023 | 76 |
About Osama E. Rahma
Osama E. Rahma is a scholar working on Oncology, Immunology, Hepatology, Surgery and Reproductive Medicine, having authored 102 papers that have together received 5.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (54 papers), Pancreatic and Hepatic Oncology Research (9 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Immunotherapy and Immune Responses (5 papers), Colorectal Cancer Surgical Treatments (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers), COVID-19 and healthcare impacts (3 papers) and Esophageal Cancer Research and Treatment (1 paper). The work is most often cited by research in Oncology (2.8k citations), Hepatology (622 citations), Immunology (358 citations), Transplantation (38 citations) and Cancer Research (75 citations). Osama E. Rahma has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Frank Stephen Hodi, Patrick Alexander Ott, Shilpa Grover, Rawad Elias, Seth M. Steinberg, Paul Raymond Kunk, Anita Giobbie‐Hurder, Austin G. Duffy, Tim F. Greten and Craig Lee Slingluff. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Clinical Cancer Research, Annals of Oncology, Cancer Immunology Immunotherapy and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.